MEDICINOVA, INC. Earnings Per Share, Basic and Diluted
MEDICINOVA, INC. (MNOV) reported Earnings Per Share, Basic and Diluted of -$0.07 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- MEDICINOVA, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.07.
- MEDICINOVA, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
- MEDICINOVA, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.09.
- MEDICINOVA, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.00.
- MEDICINOVA, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.21.
- MEDICINOVA, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.31.
- MEDICINOVA, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.30.
- MEDICINOVA, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.36.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.07 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | -$0.21 10-K · filed 2022-02-16 | |||
| 2021-09-30 | -$0.07 10-Q · filed 2021-11-12 | -$0.17 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | -$0.09 10-Q · filed 2021-08-12 | -$0.09 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$0.31 10-K · filed 2022-02-16 | |||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-12 | -$0.25 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$0.10 10-Q · filed 2021-08-12 | -$0.16 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | -$0.06 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$0.30 10-K · filed 2021-02-19 | |||
| 2019-09-30 | -$0.05 10-Q · filed 2020-10-26 | -$0.26 10-Q · filed 2020-10-26 | ||
| 2019-06-30 | -$0.09 10-Q · filed 2020-07-28 | -$0.20 10-Q · filed 2020-07-28 | ||
| 2019-03-31 | -$0.11 10-Q · filed 2020-04-23 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.36 10-K · filed 2020-02-13 |
| 2018-09-30 | -$0.16 10-Q · filed 2019-10-24 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-10-24 | -$0.35 10-Q · filed 2019-10-24 | -$0.40 derived: net income ÷ weighted average shares · filed 2019-10-24 |
| 2018-06-30 | -$0.08 10-Q · filed 2019-07-25 | -$0.19 10-Q · filed 2019-07-25 | -$0.24 derived: net income ÷ weighted average shares · filed 2019-07-25 | -$0.34 derived: net income ÷ weighted average shares · filed 2019-07-25 |
| 2018-03-31 | -$0.12 10-Q · filed 2019-04-25 | -$0.16 derived: net income ÷ weighted average shares · filed 2019-04-25 | -$0.27 derived: net income ÷ weighted average shares · filed 2019-04-25 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-04-25 |
| 2017-12-31 | -$0.02 10-K · filed 2019-02-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.23 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.32 10-K · filed 2019-02-13 |
| 2017-09-30 | -$0.11 10-K · filed 2019-02-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.27 10-Q · filed 2018-10-25 | -$0.28 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2017-06-30 | -$0.08 10-K · filed 2019-02-13 | -$0.17 10-Q · filed 2018-07-23 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.17 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2017-03-31 | -$0.09 10-K · filed 2019-02-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.09 derived: net income ÷ weighted average shares · filed 2019-02-13 |
| 2016-12-31 | -$0.04 10-K · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2019-02-13 | -$0.33 10-K · filed 2019-02-13 |
| 2016-09-30 | -$0.08 10-K · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.29 10-Q · filed 2017-10-23 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 |
| 2016-06-30 | -$0.10 10-K · filed 2018-02-13 | -$0.21 10-Q · filed 2017-07-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 |
| 2016-03-31 | -$0.11 10-K · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 |
| 2015-12-31 | -$0.09 10-K · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.00 derived: net income ÷ weighted average shares · filed 2018-02-13 | -$0.33 10-K · filed 2018-02-13 |
| 2015-09-30 | -$0.06 10-K · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.24 10-Q · filed 2016-10-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2015-06-30 | -$0.09 10-K · filed 2017-02-14 | -$0.18 10-Q · filed 2016-07-26 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2015-03-31 | -$0.09 10-K · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 |
| 2014-12-31 | -$0.10 10-K · filed 2016-02-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-14 | -$0.38 10-K · filed 2017-02-14 |
| 2014-09-30 | -$0.10 10-K · filed 2016-02-25 | -$0.00 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.28 10-Q · filed 2015-10-29 | $0.14 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-06-30 | -$0.09 10-K · filed 2016-02-25 | -$0.19 10-Q · filed 2015-07-30 | $0.15 derived: net income ÷ weighted average shares · filed 2016-02-25 | $0.05 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2014-03-31 | -$0.10 10-K · filed 2016-02-25 | $0.15 derived: net income ÷ weighted average shares · filed 2016-02-25 | $0.05 derived: net income ÷ weighted average shares · filed 2016-02-25 | -$0.07 derived: net income ÷ weighted average shares · filed 2016-02-25 |
| 2013-12-31 | $0.15 derived: net income ÷ weighted average shares · filed 2015-03-12 | $0.05 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.07 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.19 10-K · filed 2015-03-12 |
| 2013-09-30 | -$0.10 10-Q · filed 2014-11-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.37 10-Q · filed 2014-11-13 | -$0.51 derived: net income ÷ weighted average shares · filed 2015-03-12 |
| 2013-06-30 | -$0.14 10-Q · filed 2014-08-13 | -$0.27 10-Q · filed 2014-08-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2015-03-12 |
| 2013-03-31 | -$0.14 10-Q · filed 2014-05-08 | -$0.28 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.42 derived: net income ÷ weighted average shares · filed 2015-03-12 | -$0.56 derived: net income ÷ weighted average shares · filed 2015-03-12 |
| 2012-12-31 | -$0.14 10-K · filed 2014-03-27 | -$0.28 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.43 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.66 10-K · filed 2014-03-27 |
| 2012-09-30 | -$0.14 10-K · filed 2014-03-27 | -$0.28 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.52 10-Q · filed 2013-11-07 | -$0.74 derived: net income ÷ weighted average shares · filed 2014-03-27 |
| 2012-06-30 | -$0.14 10-K · filed 2014-03-27 | -$0.38 10-Q · filed 2013-08-08 | -$0.60 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.85 derived: net income ÷ weighted average shares · filed 2014-03-27 |
| 2012-03-31 | -$0.24 10-K · filed 2014-03-27 | -$0.46 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$0.71 derived: net income ÷ weighted average shares · filed 2014-03-27 | -$1.02 derived: net income ÷ weighted average shares · filed 2014-03-27 |
| 2011-12-31 | -$0.22 10-K · filed 2013-03-28 | -$0.47 derived: net income ÷ weighted average shares · filed 2013-03-28 | -$0.78 derived: net income ÷ weighted average shares · filed 2013-03-28 | -$1.20 10-K · filed 2013-03-28 |
| 2011-09-30 | -$0.25 10-K · filed 2013-03-28 | -$0.56 derived: net income ÷ weighted average shares · filed 2013-03-28 | -$0.99 10-Q · filed 2012-11-08 | |
| 2011-06-30 | -$0.31 10-K · filed 2013-03-28 | -$0.74 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$0.45 10-K · filed 2013-03-28 | |||
| 2010-12-31 | -$1.63 10-K · filed 2012-03-29 | |||
| 2010-09-30 | -$0.46 10-Q · filed 2011-11-14 | -$1.23 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$0.35 10-Q · filed 2011-08-15 | -$0.77 10-Q · filed 2011-08-15 | ||
| 2009-12-31 | -$1.68 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |